Correspondence Apr. 23 2024
Committee: International Development Committee (Department: Department for International Development)Found: pressure on the Egyp�an health system and a n umber of medical items are now in short supply, including surgical
Asked by: Siobhan Baillie (Conservative - Stroud)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024, if she will ensure that people impacted by bowel mesh are eligible for financial redress.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.
Asked by: Andrew Selous (Conservative - South West Bedfordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when her Department plans to make a decision on financial redress for those harmed by pelvic mesh or sodium valproate.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the Commissioner and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the Commissioner’s recommendations and will respond substantively in due course.
Apr. 12 2024
Source Page: Non-technical summaries granted in 2024Found: Mullet will be collected using two pole seine (3 mm mesh and 3x2 m dimensions), cast net (5 mm mesh
Apr. 09 2024
Source Page: MHRA FOI performance dataFound: Information not heldFOI 23/752How many incidents have been reported on ophthalmic surgical devices over
Mar. 21 2024
Source Page: Flagship youth employment programme hits one million milestoneFound: Most of the literature concerned osteoarthritis of the hip and knee, but it was focused on surgical (
Mentions:
1: Torrance, David (SNP - Kirkcaldy) mesh and fixation devices while a review of all surgical procedures that use polyester, polypropylene - Speech Link
2: Clark, Katy (Lab - West Scotland) I will focus on the second part of the petition, which relates to guidelines for the surgical use of - Speech Link
Asked by: Simon Jupp (Conservative - East Devon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published by the Patient Safety Commissioner on 7 February 2024, whether she has made an assessment of the potential implication for her policies of the provision of financial redress for people harmed by valproate and pelvic mesh.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.
Asked by: MacGregor, Fulton (Scottish National Party - Coatbridge and Chryston)
Question
To ask the Scottish Government what it is doing to address the reported long waiting times for patients in Glasgow seeking specialist treatment as a result of being affected by transvaginal mesh.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
NHS National Services Scotland, National Services Division (NSD) and NHS Greater Glasgow & Clyde (NHS GGC) are working to improve waiting times for access to the highly specialist Complex Mesh Surgical Service. The ongoing need for service recovery following the Covid-19 pandemic, across all areas of need in terms of women’s health, has resulted in waiting times which are disappointing, and the frustration felt by women facing significant waits is wholly understandable. For this we apologise.
However, patients are being seen, surgeries carried out, and efforts are being made to increase capacity.
The Service now also writes to patients once they are added to the outpatient waiting list, advising that their referral has been received and offering an estimated waiting time for their first appointment. This letter provides a QR code that links to the recently upgraded Complex Mesh Surgical Service Website where patients can access information about what patients can expect during their visit.
Waiting times from decision on treatment to surgery are now generally within the 12 week treatment time guarantee.
More generally, the Scottish Government is committed to eradicating long waits and we’ve already seen a significant reduction in the longest waits (over 2 years) since targets were announced. We are committed to providing further reductions through our £1bn NHS Recovery plan to increase health service capacity. We are also working closely with Health Boards to support implementation of alternative pathways and initiatives to support people being seen more quickly and increase capacity to ensure sustainability.
Asked by: Rosie Duffield (Labour - Canterbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her planned timetable is for making a decision on redress for people affected by mesh implants following the publication of The Hughes Report on 7 February 2024.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.